References |
Top |
REF 1 |
Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway. Mol Cell Biol. 2001 Apr;21(7):2475-84.
|
REF 2 |
Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR . J Biol Chem. 2003 May 9;278(19):16713-9.
|
REF 3 |
Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol Cell Biol. 2002 Oct;22(20):7158-67.
|
REF 4 |
ASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction. J Biol Chem. 2000 Oct 20;275(42):32747-52.
|
REF 5 |
Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling. Sci Signal. 2009 Oct 20;2(93):ra66.
|
REF 6 |
Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J. 2003 Dec 1;22(23):6277-88.
|
REF 7 |
An F-box protein, FBXW5, negatively regulates TAK1 MAP3K in the IL-1beta signaling pathway. Biochem Biophys Res Commun. 2009 Apr 10;381(3):412-7.
|
REF 8 |
-TrCP-mediated IRAK1 degradation releases TAK1-TRAF6 from the membrane to the cytosol for TAK1-dependent NF-B activation. Mol Cell Biol. 2012 Oct;32(19):3990-4000.
|
REF 9 |
PINK1 stimulates interleukin-1-mediated inflammatory signaling via the positive regulation of TRAF6 and TAK1. Cell Mol Life Sci. 2012 Oct;69(19):3301-15.
|
REF 10 |
MyD88 and TNF receptor-associated factor 6 are critical signal transducers in Helicobacter pylori-infected human epithelial cells. J Immunol. 2006 Mar 15;176(6):3796-803.
|
REF 11 |
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling. Nat Commun. 2016 Jun 1;7:11267.
|
REF 12 |
WDR34 is a novel TAK1-associated suppressor of the IL-1R/TLR3/TLR4-induced NF-kappaB activation pathway. Cell Mol Life Sci. 2009 Aug;66(15):2573-84.
|
REF 13 |
Transforming growth factor-beta (TGF-beta1) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-beta receptor kinase activity in mesangial cells. J Biol Chem. 2009 Aug 14;284(33):22285-96.
|
REF 14 |
Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity. 2011 Sep 23;35(3):426-40.
|
REF 15 |
Transforming growth factor beta-activated kinase 1 (TAK1) kinase adaptor, TAK1-binding protein 2, plays dual roles in TAK1 signaling by recruiting both an activator and an inhibitor of TAK1 kinase in tumor necrosis factor signaling pathway. J Biol Chem. 2010 Jan 22;285(4):2333-9.
|
REF 16 |
Reciprocal inhibition between the transforming growth factor--activated kinase 1 (TAK1) and apoptosis signal-regulating kinase 1 (ASK1) mitogen-activated protein kinase kinase kinases and its suppression by TAK1-binding protein 2 (TAB2), an adapter protein for TAK1. J Biol Chem. 2012 Jan 27;287(5):3381-91.
|
REF 17 |
Constitutive association of TGF-beta-activated kinase 1 with the IkappaB kinase complex in the nucleus and cytoplasm of human neutrophils and its impact on downstream processes. J Immunol. 2010 Apr 1;184(7):3897-906.
|
REF 18 |
Autoactivation of transforming growth factor beta-activated kinase 1 is a sequential bimolecular process. J Biol Chem. 2010 Aug 13;285(33):25753-66.
|
REF 19 |
TAB3, a new binding partner of the protein kinase TAK1. Biochem J. 2004 Feb 15;378(Pt 1):27-34.
|
REF 20 |
HSP90 is required for TAK1 stability but not for its activation in the pro-inflammatory signaling pathway. FEBS Lett. 2008 Dec 10;582(29):4023-31.
|
REF 21 |
HIV-1 Vpr stimulates NF-B and AP-1 signaling by activating TAK1. Retrovirology. 2014 Jun 9;11:45.
|
REF 22 |
Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling. Cell Signal. 2015 Dec;27(12):2524-33.
|
REF 23 |
Cereblon negatively regulates TLR4 signaling through the attenuation of ubiquitination of TRAF6. Cell Death Dis. 2016 Jul 28;7(7):e2313.
|
REF 24 |
Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3. Biochem J. 2017 Jun 26;474(13):2235-2248.
|
REF 25 |
Salt-inducible kinases 1 and 3 negatively regulate Toll-like receptor 4-mediated signal. Mol Endocrinol. 2013 Nov;27(11):1958-68.
|
REF 26 |
TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science. 1996 May 24;272(5265):1179-82.
|
REF 27 |
The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors. Sci Signal. 2015 Jun 2;8(379):ra54.
|
REF 28 |
TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 2001 Jul 19;412(6844):346-51.
|
REF 29 |
ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. Mol Cell. 2010 Oct 8;40(1):75-86.
|
REF 30 |
Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2. J Biol Chem. 2005 Feb 25;280(8):7359-68.
|
REF 31 |
Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat Immunol. 2007 May;8(5):504-13.
|
REF 32 |
Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways. EMBO J. 2007 Apr 4;26(7):1794-805.
|
REF 33 |
A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem. 2003 May 16;278(20):18485-90.
|
REF 34 |
The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 1999 Mar 18;398(6724):252-6.
|
REF 35 |
Retroviral oncoprotein Tax deregulates NF-kappaB by activating Tak1 and mediating the physical association of Tak1-IKK. EMBO Rep. 2007 May;8(5):510-5.
|
REF 36 |
Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by TAB1. FEBS Lett. 2000 Jun 2;474(2-3):141-5.
|
REF 37 |
Direct activation of protein kinases by unanchored polyubiquitin chains. Nature. 2009 Sep 3;461(7260):114-9.
|
REF 38 |
STAT3 regulates Nemo-like kinase by mediating its interaction with IL-6-stimulated TGFbeta-activated kinase 1 for STAT3 Ser-727 phosphorylation. Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4524-9.
|
REF 39 |
Osmotic stress activates the TAK1-JNK pathway while blocking TAK1-mediated NF-kappaB activation: TAO2 regulates TAK1 pathways. J Biol Chem. 2006 Sep 29;281(39):28802-10.
|
REF 40 |
Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway. J Biol Chem. 2006 Dec 29;281(52):39891-6.
|
REF 41 |
TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J Biol Chem. 2000 Mar 10;275(10):7359-64.
|
REF 42 |
Helicobacter pylori activates NF-B by inducing Ubc13-mediated ubiquitination of lysine 158 of TAK1. J Cell Biochem. 2013 Oct;114(10):2284-92.
|
REF 43 |
USP18 inhibits NF-B and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex. J Exp Med. 2013 Jul 29;210(8):1575-90.
|
REF 44 |
Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression. Cancer Res. 2008 Mar 1;68(5):1462-70.
|
REF 45 |
USP4 targets TAK1 to downregulate TNF-induced NF-B activation. Cell Death Differ. 2011 Oct;18(10):1547-60.
|
REF 46 |
LATS2 inhibits the activity of NF- B signaling by disrupting the interaction between TAK1 and IKK. Tumour Biol. 2015 Sep;36(10):7873-9.
|
REF 47 |
IFIT5 positively regulates NF-B signaling through synergizing the recruitment of IB kinase (IKK) to TGF--activated kinase 1 (TAK1). Cell Signal. 2015 Dec;27(12):2343-54.
|
REF 48 |
pVHL mediates K63-linked ubiquitination of IKK, leading to IKK inactivation. Cancer Lett. 2016 Dec 1;383(1):1-8.
|
REF 49 |
USP10 inhibits genotoxic NF-B activation by MCPIP1-facilitated deubiquitination of NEMO. EMBO J. 2013 Dec 11;32(24):3206-19.
|
REF 50 |
TAB4 stimulates TAK1-TAB1 phosphorylation and binds polyubiquitin to direct signaling to NF-kappaB. J Biol Chem. 2008 Jul 11;283(28):19245-54.
|
REF 51 |
Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation. J Biol Chem. 1999 Apr 9;274(15):10641-8.
|
REF 52 |
Molecular determinants of NF-kappaB-inducing kinase action. Mol Cell Biol. 1998 Oct;18(10):5899-907.
|
REF 53 |
Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46.
|
REF 54 |
TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation. J Biol Chem. 2005 Dec 30;280(52):43056-63.
|
REF 55 |
Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J Biol Chem. 2006 May 12;281(19):13636-43.
|
REF 56 |
A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage. Mol Cell Biol. 2011 Jul;31(14):2774-86.
|
REF 57 |
AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway. Biochem Pharmacol. 2010 Oct 15;80(8):1210-20.
|
REF 58 |
TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta ), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1. J Biol Chem. 2003 Jan 24;278(4):2286-93.
|
REF 59 |
SPATA2 links CYLD to the TNF- receptor signaling complex and modulates the receptor signaling outcomes. EMBO J. 2016 Sep 1;35(17):1868-84.
|
REF 60 |
Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell. 2006 Apr 21;22(2):245-57.
|
REF 61 |
TAK1 is a central mediator of NOD2 signaling in epidermal cells. J Biol Chem. 2008 Jan 4;283(1):137-44.
|
REF 62 |
Reciprocal cross-talk between Nod2 and TAK1 signaling pathways. J Biol Chem. 2004 Jun 11;279(24):25876-82.
|